Anika Therapeutics | ANIK - Trade Debtors


Anika Therapeutics reported $29.33M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Agenus USD 22.34M 107K Mar/2026
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 8.56M 7.13M Jun/2026
Enanta Pharmaceuticals USD 40.16M 1.52M Dec/2024
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Insmed USD 215.32M 36.77M Jun/2026
Integra LifeSciences USD 267.19M 2.78M Jun/2026
Intrexon USD 1.02M 559K Jun/2024
J&J USD 19.05B 3.49B Jun/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sanofi EUR 492M 10M Jun/2026
Smith & Nephew USD 1.52B 36M Jun/2026
Stryker USD 3.74B 172M Jun/2026
Veracyte USD 54.18M 4.06M Jun/2026
Xencor USD 42.23M 30.23M Jun/2026
Zimmer Biomet Holdings USD 1.77B 40.9M Jun/2026